Nerve Growth Factor Eye Drops Show Four-Year Safety in Children With Optic Pathway Gliomas
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A 12-year single-center study of 301 children with neurofibromatosis type 1 maps the disorder's genetic and clinical landscape, linking specific ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine